| Literature DB >> 9489242 |
Abstract
Commodification of low-cost diagnostic technologies (LCDTs) carries the risk of an unintended and potentially worrisome shift in how we conceive of health assessment. Optimizing practice requires a balanced understanding of both the beneficial and harmful impact of the use of LCDTs and the development of system incentives for appropriate use.Mesh:
Year: 1997 PMID: 9489242 DOI: 10.1017/s0266462300009971
Source DB: PubMed Journal: Int J Technol Assess Health Care ISSN: 0266-4623 Impact factor: 2.188